The lateral flow assay (LFA) market studied was anticipated to grow with a CAGR of nearly 3.9% during the forecast period. The major factors attributing to the growth of the market are a rise in the global prevalence of infectious diseases, HIV, cancers, which necessitate novel diagnostic methods for efficient treatment to eradicate the growing mortality rate. For instance, according to the Joint United Nations Programme on HIV and AIDS (UNAIDS), in 2019, 24.5 million people with HIV were accessing antiretroviral therapy globally. Additionally, increased participation of the government to control the outbreaks of the infectious diseases and the increasing awareness programs to enhance the spread of infections, diagnosis, and prevention, along with the launch of immediate diagnosis systems at home care settings, are expected to contribute to the growth of the global market during the forecast period.
Get a Sample Copy of this Report with Graphs and Charts: https://www.sdki.us/sample-request-89216
Key Market Trends
Clinical Testing Sub-segment by Application is Expected to Hold the Largest Market Share in the Lateral Flow Assay Market
The clinical testing segment is anticipated to hold the largest market share in the LFA market due to its importance in identifying the detection of the disease with a rise in the incidence of infectious diseases. The increased demand for the segment is owing to an increase in the new approvals of self-test devices, such as Atomo HIV Self-Test, TRUSTline HIV-Ab/Ag 4th Gen Rapid Test, Dr Trust Hiv Sure, and others, developed in the recent years. These self-test devices and kits help the patients in assurance, earlier diagnosis, enhanced convenience, and ease of use, which are likely to fuel the market.
North America Dominates the Market and it is Expected to do the Same in the Forecast Period
North America is expected to dominate the overall LFA market throughout the forecast period owing to a rise in the incidence of various infectious diseases such as Lyme disease, tuberculosis, and increased mortality rate associated with HIV/AIDS in the region. In North America, the United States holds the largest market share due to increased patient pool and high affordability with increasing disposable income.
For instance, as per the US Department of Health & Human Services report published in January 2020, about 37,832 people in the US were diagnosed with HIV in 2018, and 38,000 new HIV infections still occur in the United States. It has also been reported that there is a rapid spread of various infectious diseases such as meningitis, urinary tract infections necessitating the immediate diagnosis demanding the fast diagnostic test devices fueling the market. Furthermore, the increased adoption rate of advanced infrastructure, the volume of diagnostic centers, rise in awareness among the people are factors estimated to boost the market in the region, contributing to its outstanding share of the global market revenue during the forecast period.
Related Reports:
Lateral Flow Assay Market Size, Development Status, Top Manufacturers, and Forecasts 2022-2031
Rare Neurological Disease Treatment Market Size Projected to Deliver Greater Revenues during the Forecast Period 2022-2031
Sleep Apnea Implant Market Size: Key Facts, Dynamics, Segments and Forecast Predictions Presented 2022-2031
Home Healthcare Market Size Key Insights Based on Product Type, End-use and Regional Demand 2022-2031
Oseltamivir Market Size: Dynamics, Segments, and Demand Analysis 2022-2031
Latex Medical Disposables Market Size: Facts, Figures and Analytical Insights 2022-2031
Myeloproliferative Disorders (MPD) Treatment Market Size Outlook, Share and Growth and Forecast Assumptions 2022-2031
